Science Highlights

Home
News
Science Highlights

Filter by
Categories
Tags
Authors
Show all

All
Corporate News
Events
Science Highlights

All
Adenosine receptor
Adrenergic
advantages of fluorescent probes
affinity binding
Angiotensin AT1
Bioga award
blood pressure
cannabinoid receptors
CB1
CB2
CELT-228
CELT-335
Celtarys
Celtarys Research
chemspace
colorectal cancer
Competition binding assay
confocal microscopy
Custom service
distribution agreement
Dopamine D3 receptor
Drug discovery
E3 LIGASE
EC50
ELRIG
Flow cytometry
Fluorescence polarization
fluorescence polarization assay
fluorescence polarization assays
fluorescent dyes applications
fluorescent dyes used in microscopy
fluorescent ligand
fluorescent ligands
Fluorescent polarization
fluorescent probes
fluorescent probes for high-throughput screening
fluorescent probes for nanoscopic imaging of mitochondria
fluorescent probes uses
fluorescent-conjugate toolbox
Föster Resonance Energy Transfer
FRET
Functional studies
GClips
GLP1R
GPCR
GPCR fluorescent probes
GPCR imaging
high throughput screening
live and fixed cells
luorescent mitochondrial probe live imaging
LUXendins
Membrane extract
Monolith
Nanotemper
oncology
Oncomet
openscreen
phytocannabinoids
Plate reader
Poster
Radioligands
ratio range
Receptor characterization
rhodopsin
SDDN
Sigma receptors
SLAS
strategic research cooperation
sympathetic
target engagement
transmembrane proteins
Twist Bioscience
Ubiquitin
VHL

All
base
celtarys
marcos
Patricia Simbionte
sabrina
Sandra Ortigueira
seo
Webmaster

28 December 2021

Celtarys exclusive fluorescent ligands for cannabinoid receptors used to analyze binding of naturally occurring Δ9-tetrahydrocannabinol-derivatives to cannabinoid CB1 and CB2 receptors

Don’t miss the new article by Dr. Gemma Navarro and Dr. Rafael Franco about cannabinoid CB1 and CB2 receptors signaling. They have successfully used CELT-335, one […]

14 September 2021

Positive allosteric mechanisms of adenosine A1 receptor-mediated analgesia

Impressive paper published in Nature journal tackling allosteric modulation of adenosine A1 receptor (A1R) as a promising therapeutic approach of non-opioid analgesic agents to treat neuropathic pain. […]

31 August 2021

Trends in kinase drug discovery: targets, indications and inhibitor design

Abstract: The FDA approval of imatinib in 2001 was a breakthrough in molecularly targeted cancer therapy and heralded the emergence of kinase inhibitors as a key […]